세계의 KRAS 저해제 시장 : 기회와 임상시험 전망
Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025
상품코드 : 979967
리서치사 : KuicK Research
발행일 : 2021년 01월
페이지 정보 : 영문 125 Pages
US $ 2,000 ₩ 2,218,000
Unprintable PDF (Single User License)
US $ 2,600 ₩ 2,883,000
CD-ROM
US $ 3,600 ₩ 3,992,000
Printable PDF (Multi-User License)


한글목차

KRAS 저해제는 시장에 관련된 훌륭한 연구개발 파이프라인에 의해 암 치료제 시장의 주요 신규 부문 중 하나라고 말할 수 있습니다.

세계의 KRAS 저해제(KRAS Inhibitor) 시장에 대해 조사분석했으며, 시장 기회, 시장 점유율, 임상시험 중인 약제, 시장 동향, 시장 역학, 향후 기회 전망에 대한 정보를 제공합니다.

목차

제1장 KRAS 저해제의 서론

제2장 암에서 KRAS 저해제의 역할

제3장 KRAS 저해제 : 작용기전

제4장 폐암을 표적으로 하는에서의 KRAS 저해제

제5장 췌장암에서의 KRAS 저해제

제6장 대장암에서의 KRAS 저해제

제7장 기타 암에 대한 KRAS 저해제

제8장 세계의 KRAS 단백질 저해제 임상시험 지표

제9장 세계의 KRAS 단백질 저해제 임상 파이프라인 : 기업별, 적응증별, 단계별

제10장 세계의 KRAS 저해제 시장 분석 : 현재 시나리오

제11장 세계의 KRAS 저해제 시장 동향

제12장 세계의 KRAS 저해제 시장 역학

제13장 세계의 KRAS 저해제 시장 기회 전망

제14장 경쟁 구도

LSH 21.01.13
영문 목차

영문목차

"Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" Report Highlights:

The accelerating pace of the cancer cases at global level has led to the arrival of a unique and application-based therapy market, known as KRAS inhibitors. In the past few years, the therapy has been able to show favorable response involving the cell cycle, which is the ultimate target of the cancer cells for continue its proliferation and division in the patients. A cluster of innovative drugs that target KRAS protein has been developed by the researchers and bunch of novel product candidate targeting KRAS protein is currently active in the clinical trials. It can be stated for KRAS inhibitors that it is among the top emerging sectors of the cancer therapeutics market which is due to the splendid research and development pipeline associated with the market. The entire market associated with KRAS inhibitors, in a very short period of time has been able to shift the entire cancer landscape, thus resulting in the standard care of cancer treatment with appropriate opportunities to the patients and the investors.

The drugs developed under the market, inhibits KRAS protein and further the important signaling pathways, ultimately leading to the cell cycle arrest and killing of the cancer cells. Such switching on and off of the cell cycle with the help of hundreds of KRAS inhibitors developed by the researchers is estimated to improve the overall paradigm for efficient targeting, minimal side-effect development, increased effectiveness and efficiency against different types of tumor antigens. The overall increase in the spending for research-based formulas for KRAS inhibitors is also estimated to develop a market that is worth trillions of dollars and decrease the burden that is getting reflected in the cancer therapeutics market with respect to efficient targeting of the cancer cells.

Despite having numerous challenges which were set by the already driven cancer therapies in the market such as chemotherapy or radiation therapy, the novel KRAS inhibitor market has made its impact on the overall running paradigm of cancer therapeutics at global level. The pharmaceutical research sector affiliated with KRAS inhibitor market has weathered down the complex challenges of developing drug candidates with 100% efficacy.

Now-a-days, the KRAS inhibitor market at global level is getting adjoined with novel techniques and technologies that are apparently leading to reinventing the entire cancer market and research-based sector. No doubt, the entire market has led to an opening of novel frontiers that could unravel the complex mechanism of cancer cells and how it could get regulated by controlling the proteins responsible for cell cycle. In addition to this, some of the parameters that are leading to the exponential growth of the market in the past few years include: healthcare benefits associated with the drug candidates and increased awareness about the side-effects of old and traditional cancer therapies such as chemotherapy.

As per the "Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025" report findings, it can be estimated that the market is completely getting catalyzed by the increased applications of healthcare benefits and variety of disruptive technologies and drug candidates that are available in the market for different types of tumor antigens. In the novel cancer therapeutics market, partly driven by KRAS inhibitor is believed to be overcoming all the challenges that were difficult to crack before the arrival of the KRAS inhibitor therapy.

Table of Contents

1. Introduction to KRAS Inhibitors

2. Role of KRAS Inhibitors in Cancer

3. KRAS Inhibitors - Mode of Action

4. KRAS Inhibitors For Targeting Lung Cancer

5. KRAS Inhibitors in Pancreatic Cancer

6. KRAS Inhibitors for Colorectal Cancer

7. KRAS inhibitors For Other Cancers

8. Global KRAS Protein inhibitors Clinical Trials Indicators

9. Global KRAS Protein Inhibitors Clinical Pipeline By Company, Indication & Phase

10. Global KRAS Inhibitors Market Analysis: Current Scenario

11. Global KRAS Inhibitors Market Trends

12. Global KRAS Inhibitors Market Dynamics

13. Global KRAS Inhibitors Market Future Opportunity Outlook

14. Competitive Landscape

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기